Home β€Ί Healthcare β€Ί Vaccines β€Ί Global Pet Vaccine Market

Global Pet Vaccine Market - Strategic Insights and Forecasts (2025-2030)

πŸ“₯ Download Free SampleπŸ’¬ Speak to Analyst
$3,950
Single User License
Access Full Insights
Report OverviewSegmentationTable of ContentsCustomize Report

Table of Contents

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations

3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL PET VACCINE MARKET BY ANIMAL TYPE

5.1. Introduction

5.2. Canine

5.3. Feline

5.4. Equine

5.5. Avian

5.6. Others

6. GLOBAL PET VACCINE MARKET BY VACCINE TYPE

6.1. Introduction

6.2. Core

6.2.1. Rabbies

6.2.2. Distemper

6.2.3. Others

6.3. Non-Core

6.3.1. Bordetella

6.3.2. Lyme

6.3.3. Giardia

7. GLOBAL PET VACCINE MARKET BY ADMINISTRATION

7.1. Introduction

7.2. Injectable Vaccine

7.3. Intransal Vaccine

7.4. Oral Vaccine

8. GLOBAL PET VACCINE MARKET BY DISTRIBUTION CHANNEL

8.1. Introduction

8.2. Veterinary Hospitals & Clinics

8.3. Retail Pharmacies

8.4. Online Pharmacies

9. GLOBAL PET VACCINE MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. USA

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. Germany

9.4.2. France

9.4.3. United Kingdom

9.4.4. Spain

9.4.5. Others

9.5. Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Others

9.6. Asia Pacific

9.6.1. China

9.6.2. Japan

9.6.3. India

9.6.4. South Korea

9.6.5. Thailand

9.6.6. Taiwan

9.6.7. Indonesia

9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. Zoetis Inc.

11.2. Merck & Co., Inc.

11.3. Boehringer Ingelheim Animal Health GmbH

11.4. Elanco Animal Health Inc.

11.5. Ceva

11.6. Virbac

11.7. HIPRA

11.8. Biogénesis Bagó

11.9. Kemin Industries Inc.

12. APPENDIX

12.1. Currency

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology

12.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES

REPORT DETAILS

Report ID:KSI061611148
Published:Jan 2026
Pages:149
Format:PDF, Excel, PPT, Dashboard
πŸ“₯ Download SampleπŸ“ž Speak to AnalystπŸ“§ Request Customization

Need Assistance?

Our research team is available to answer your questions.

Contact Us